MX2010003488A - Composiciones de oftalmologia basadas en polisacarido y acido hialuronico de semillas de tamarindo. - Google Patents

Composiciones de oftalmologia basadas en polisacarido y acido hialuronico de semillas de tamarindo.

Info

Publication number
MX2010003488A
MX2010003488A MX2010003488A MX2010003488A MX2010003488A MX 2010003488 A MX2010003488 A MX 2010003488A MX 2010003488 A MX2010003488 A MX 2010003488A MX 2010003488 A MX2010003488 A MX 2010003488A MX 2010003488 A MX2010003488 A MX 2010003488A
Authority
MX
Mexico
Prior art keywords
hyaluronic acid
combination
tamarind seed
compositions based
seed polysaccharide
Prior art date
Application number
MX2010003488A
Other languages
English (en)
Spanish (es)
Inventor
Antonio Del Prete
Marco Sanso
Original Assignee
Rmfa Trading S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmfa Trading S A filed Critical Rmfa Trading S A
Publication of MX2010003488A publication Critical patent/MX2010003488A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2010003488A 2007-10-02 2008-10-02 Composiciones de oftalmologia basadas en polisacarido y acido hialuronico de semillas de tamarindo. MX2010003488A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000510A ITRM20070510A1 (it) 2007-10-02 2007-10-02 Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
PCT/IT2008/000626 WO2009044423A1 (en) 2007-10-02 2008-10-02 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid

Publications (1)

Publication Number Publication Date
MX2010003488A true MX2010003488A (es) 2010-08-31

Family

ID=40314052

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003488A MX2010003488A (es) 2007-10-02 2008-10-02 Composiciones de oftalmologia basadas en polisacarido y acido hialuronico de semillas de tamarindo.

Country Status (14)

Country Link
US (1) US8455462B2 (enExample)
EP (1) EP2197456B1 (enExample)
JP (1) JP5542674B2 (enExample)
KR (1) KR101570966B1 (enExample)
AT (1) ATE499106T1 (enExample)
CA (1) CA2701721C (enExample)
DE (1) DE602008005173D1 (enExample)
ES (1) ES2361529T3 (enExample)
IT (1) ITRM20070510A1 (enExample)
MX (1) MX2010003488A (enExample)
PL (1) PL2197456T3 (enExample)
PT (1) PT2197456E (enExample)
RU (1) RU2493855C2 (enExample)
WO (1) WO2009044423A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7726809B2 (en) * 2005-02-09 2010-06-01 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
IT1396607B1 (it) * 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
HUE026862T2 (en) 2010-05-24 2016-07-28 Indena Spa Combined vegetable extracts for use in the treatment of microbiological infections
DK2575973T3 (en) * 2010-05-24 2017-08-14 Indena Spa TAMARED SEED POLYSACCHARIDE AND FERULA HERMONIS EXTRACT USED IN TREATMENT OF INFLAMMATORY DISEASES
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
EP2883931A1 (en) * 2013-12-12 2015-06-17 Omya International AG Improved gel stability
CA2945631C (en) 2014-04-15 2023-04-11 Novintethical Pharma Sa Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
EP3103438B1 (en) 2015-06-11 2018-11-14 Novintethical Pharma SA Topical nasal compositions containing xyloglucans for use as decongestans
TW201707719A (zh) * 2015-07-13 2017-03-01 國立大學法人東北大學 視神經保護用組成物
AR108280A1 (es) 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
IT201600108848A1 (it) * 2016-10-27 2018-04-27 Giuliani Spa Composizioni dermatologiche
WO2019025986A1 (en) * 2017-08-02 2019-02-07 Shilpa Medicare Limited OPHTHALMIC COMPOSITIONS OF CYCLOSPORINE
US11129862B2 (en) 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
MA53171A (fr) * 2018-07-18 2021-05-26 Atg 20 S R L Composition comprenant de la glycyrrhizine et ses utilisations cosmétiques et pharmaceutiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
DK1021204T3 (da) * 1997-09-26 2006-05-08 Noven Pharma Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler
AU770803B2 (en) * 1998-12-23 2004-03-04 Idea Ag Improved formulation for topical non-invasive application in vivo
WO2005039619A1 (en) * 2003-10-03 2005-05-06 Allergan, Inc. Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
US7726809B2 (en) 2005-02-09 2010-06-01 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法

Also Published As

Publication number Publication date
PL2197456T3 (pl) 2012-07-31
DE602008005173D1 (de) 2011-04-07
ATE499106T1 (de) 2011-03-15
EP2197456B1 (en) 2011-02-23
KR101570966B1 (ko) 2015-11-23
EP2197456A1 (en) 2010-06-23
WO2009044423A1 (en) 2009-04-09
JP5542674B2 (ja) 2014-07-09
JP2010540619A (ja) 2010-12-24
CA2701721A1 (en) 2009-04-09
ITRM20070510A1 (it) 2009-04-03
PT2197456E (pt) 2011-05-18
RU2010117173A (ru) 2011-11-10
ES2361529T3 (es) 2011-06-17
RU2493855C2 (ru) 2013-09-27
US20100279981A1 (en) 2010-11-04
KR20100091151A (ko) 2010-08-18
US8455462B2 (en) 2013-06-04
CA2701721C (en) 2016-02-23

Similar Documents

Publication Publication Date Title
PT2197456E (pt) Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico
MY159463A (en) Method and composition for treating ocular hypertension and glaucoma
MY210233A (en) Methods and compositions for topical delivery
IN2012DN03632A (enExample)
JP2010540619A5 (enExample)
MX2010003774A (es) Formulaciones oftalmicas acuosas.
MY191349A (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
MX2010004834A (es) Composiciones de analogos de prostaglandina y metodos para tratar las condiciones relacionadas al epitelio.
NZ608202A (en) Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
WO2006071548A3 (en) Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases
EP4371615A3 (en) Treatment of amd using aav sflt-1
UA95105C2 (ru) Применение производного лактамида для снижения токсичности в препарате, который может соприкасаться с кожей или глазами человека или животного, производные лактамида и способы их получения
TW200833341A (en) 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions
MX2009004467A (es) Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk).
WO2009024677A3 (fr) Utilisation d ' acide hyaluronique pour la preparation de compositions destinees a l' amelioration de la fonction de protection de la peau, de l' oeil et des muqueuses
MY179527A (en) Catecholamine derivatives useful for the treatment of parkinson's disease
MX2011014025A (es) Composicion farmaceutica que comprende sales de rotigotina (acidio o na), especialmente para iontoforesis.
MX2012003759A (es) Metodos y composiciones para tratamiento de fibrosis ocular.
MY149505A (en) Hyaluronic acid binary mixtures and therapeutic use thereof
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
WO2009130422A3 (fr) N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
UA95224C2 (ru) Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения
WO2021074649A3 (en) Methods of promoting scfa production by gut microbiota

Legal Events

Date Code Title Description
FG Grant or registration